| Structure |
Chemical Name |
CAS |
MF |
 |
Sodium 1-(2-hydroxyethyl)-1H-tetrazol-5-ylthiolate |
400827-72-7 |
C3H5N4NaOS |
![(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate](/CAS/20200331/GIF/1187595-90-9.gif) |
(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate |
1187595-90-9 |
C22H27N7O4S |
 |
(6R,7S)-Cefuroxime |
|
C16H16N4O8S |
![(6-methyl-2-p-tolyl-2,3-dihydro-imidazo[1,2-a]pyridin-3-yl)-oxoacetic acid](/CAS/20200401/GIF/927820-48-2.gif) |
(6-methyl-2-p-tolyl-2,3-dihydro-imidazo[1,2-a]pyridin-3-yl)-oxoacetic acid |
927820-48-2 |
C17H14N2O3 |
 |
3-Hydroxy-N-methyl-3-phenyl-propylamine |
42142-52-9 |
C10H15NO |
 |
5-Benzylthio-1H-tetrazole |
21871-47-6 |
C8H8N4S |
 |
Triphenylsulfonium chloride |
4270-70-6 |
C18H15ClS |
 |
5-GERANOXY-7-METHOXYCOUMARIN |
7380-39-4 |
C20H24O4 |
 |
ACETIC ACID 2-PHENOXYETHYL ESTER |
6192-44-5 |
C10H12O3 |
 |
ETHYL 1-HYDROXYCYCLOPENTANE-CARBOXYLATE |
41248-23-1 |
C8H14O3 |
 |
Danshen injection intermediate |
|
|
 |
Azacitidine Isomer |
|
|
 |
6-FLUORO-4-HYDROXYCOUMARIN |
1994-13-4 |
C9H5FO3 |
 |
Cefazolin Related Compound D |
|
|
 |
Sugammadex sodium hexabromide intermediate |
|
|
 |
(3S,5R,2R,3S)-posaconazole |
|
|
 |
2',3',5'-TRI-O-BENZOYLINOSINE |
6741-88-4 |
C31H24N4O8 |
 |
5-AMINO-2'-DEOXYURIDINE FREE BASE |
5536-30-1 |
C9H13N3O5 |
 |
ETHYL 3-BUTENOATE |
1617-18-1 |
C6H10O2 |
 |
2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile |
1187595-85-2 |
C7H10N2O2S |
 |
4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
170985-61-2 |
C37H42F2N8O4 |
 |
Velpatasvir intermediate |
1378391-45-7 |
C44H53N7O7 |
 |
Br-PEG1-NHBoc |
164332-88-1 |
C9H18BrNO3 |
![(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride](/CAS/20180703/GIF/1701403-10-2.gif) |
(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride |
1701403-10-2 |
C22H23ClN6O |
![(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid](/CAS/20180703/GIF/1616342-45-0.gif) |
(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid |
1616342-45-0 |
C15H16N2O6 |
 |
Azithromycin F |
612069-26-8 |
C38H72N2O13 |
 |
4-IMIDAZOLEACETIC ACID HYDROCHLORIDE |
3251-69-2 |
C5H7ClN2O2 |
 |
Coumarin 102 |
41267-76-9 |
C16H17NO2 |
![2-Oxazolidinone,3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-(phenylmethyl)-,(4S)-](/CAS/GIF/852148-49-3.gif) |
2-Oxazolidinone,3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-(phenylmethyl)-,(4S)- |
852148-49-3 |
C21H22FNO4 |
![8-bromo-1,4-dioxaspiro[4.5]decane](/CAS/20150408/GIF/68278-51-3.gif) |
8-bromo-1,4-dioxaspiro[4.5]decane |
68278-51-3 |
C8H13BrO2 |
 |
Retigabine Dihydrochloride |
150812-13-8 |
C16H20Cl2FN3O2 |
 |
10β-(2'-naphthyloxy)dihydroartemisinin |
255730-16-6 |
|
 |
QUINUCLIDINE |
100-76-5 |
C7H13N |
 |
6-nitrocoumarin |
2725-81-7 |
C9H5NO4 |
 |
Cefazolin Impurity I(EP) |
|
|
 |
Cefoperazone Dimer A |
|
|
 |
(S)-1-Amino-3-chloro-2-propanol hydrochloride |
34839-13-9 |
C3H9Cl2NO |
 |
9β,11β-Epoxy-17,21-dihydroxy-16β-methylpregna-1,4-diene-3,20-dione |
981-34-0 |
C22H28O5 |
 |
Ethyl 3-(N,N-dimethylamino)acrylate |
1117-37-9 |
C7H13NO2 |
 |
3,4-Dichloro-6-(trifluoromethyl)toluene |
74483-51-5 |
C8H5Cl2F3 |
![BENZYL [2-AMINO-2-(HYDROXYIMINO)-1,1-DIMETHYLETHYL]CARBAMATE](/CAS/GIF/518047-98-8.gif) |
BENZYL [2-AMINO-2-(HYDROXYIMINO)-1,1-DIMETHYLETHYL]CARBAMATE |
518047-98-8 |
C12H17N3O3 |
![4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine](/CAS/GIF/941685-27-4.gif) |
4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine |
941685-27-4 |
C15H21N5OSi |
 |
4,7-Bis(2-bromo-5-thienyl)-2,1,3-benzothiadiazole |
288071-87-4 |
C14H6Br2N2S3 |
 |
(1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone |
895152-66-6 |
C16H19NO |
![Platinum, dichloro(1,2-cyclohexanediamine-N,N')-, [sp-4-2-(1R-trans)]-](/CAS/20180713/GIF/61848-66-6.gif) |
Platinum, dichloro(1,2-cyclohexanediamine-N,N')-, [sp-4-2-(1R-trans)]- |
61848-66-6 |
C6H12Cl2N2Pt |
 |
20-HYDROXY PROSTAGLANDIN E2 |
57930-95-7 |
C20H32O6 |
 |
NA |
|
|
![2,3,4,5-Tetrahydro-N,N-dimethyl-1-[(4-methylphenyl)sulfonyl]-1H-1-benzazepin-5-amine](/CAS2/GIF/181210-18-4.gif) |
2,3,4,5-Tetrahydro-N,N-dimethyl-1-[(4-methylphenyl)sulfonyl]-1H-1-benzazepin-5-amine |
181210-18-4 |
C19H24N2O2S |
 |
6-(Phthalimidomethyl)morphanthridine |
74860-00-7 |
C23H16N2O2 |
![(3R,3αS,6αR)-Hydroxyhexa-hydrofuro[2,3-β]furan-3-yl acetate](/CAS/20180808/GIF/186488-43-7.gif) |
(3R,3αS,6αR)-Hydroxyhexa-hydrofuro[2,3-β]furan-3-yl acetate |
186488-43-7 |
C8H12O4 |
 |
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione |
853029-57-9 |
C20H17BrN6O2 |
 |
(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one.HCl |
898543-06-1 |
C14H17N3O4.ClH |
 |
5-broMo-2-chloro-N-cyclopentylpyriMidin-4-aMine |
733039-20-8 |
C9H11BrClN3 |
 |
DMT-2′O-MOE-rMeC(bz) Phosphoramidite |
163759-94-2 |
C50H60N5O10P |
 |
7-DEAZA-2'-DEOXYINOSINE |
97224-58-3 |
C11H13N3O4 |
 |
5-Methyl-3-phenylisoxazole-4-carbonyl chloride |
16883-16-2 |
C11H8ClNO2 |
 |
Benfotiamine |
22457-89-2 |
C19H23N4O6PS |
![3H-3-Azadibenzo[g,ij]naphth[2,1,8-cde]azulene](//CAS/20200611/GIF/2408302-78-1.gif) |
3H-3-Azadibenzo[g,ij]naphth[2,1,8-cde]azulene |
2408302-78-1 |
C22H13N |
![tert-butyl (R)-1-amino-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate](/) |
tert-butyl (R)-1-amino-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate |
|
|
 |
(3S,4S,5S)-Oseltamivir |
|
|
 |
Edoxaban Impurity 19 (1S,2R,4S) Mesylate |
1807315-98-5 |
C17H26ClN5O6S |
 |
(9H-fluoren-9-yl)methyl (R)-(4-cyclohexyl-1-(methylamino)-1-oxobutan-2-yl)carbamate |
|
|
 |
1-Pyrrolidinecarboxylic acid, 3-(4-bromo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester, (3R)- |
2198312-46-6 |
C12H18BrN3O2 |
 |
3-(3-(Trifluoromethyl)phenyl)propan-1-ol |
78573-45-2 |
C10H11F3O |
 |
N-ForMyl- |
104872-27-7 |
C29H53NO5 |
![3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine](/CAS/GIF/1022150-12-4.gif) |
3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine |
1022150-12-4 |
C22H22N6O |
 |
4-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline |
190728-25-7 |
C17H16N2O3 |
 |
McMMAE |
863971-24-8 |
C49H78N6O10 |
 |
2-Amino-4-bromo-3-fluorobenzoic acid |
1416013-62-1 |
C7H5BrFNO2 |
 |
AMoxicillin TriMer |
174391-69-6 |
C48H57N9O15S3 |
 |
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
1246391-73-0 |
C37H42F2N8O4 |
 |
Neratinib Maleate |
915942-22-2 |
C34H33ClN6O7 |
 |
Oclacitinib Maleate(PF-03394197) |
1208319-27-0 |
C19H27N5O6S |
 |
Meropenem IMP A |
1053703-36-8 |
C17H27N3O6S |
 |
4,6,7-trihydroxycoumarin |
22649-24-7 |
C9H6O5 |
 |
Velpatasvir intermediate |
1378391-42-4 |
C31H34BrNO8 |
 |
Methyl 4-isopropyl-3,5-dimethoxybenzoate |
344396-17-4 |
C13H18O4 |
![(2S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-Pyrrolidinecarboxylic acid phenylmethyl ester](/CAS/20180703/GIF/1420478-88-1.gif) |
(2S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-Pyrrolidinecarboxylic acid phenylmethyl ester |
1420478-88-1 |
C18H18BrN5O2 |
 |
(9H-fluoren-9-yl)methyl (4-(dimethoxymethyl)phenyl)carbamate |
475160-88-4 |
C24H23NO4 |
 |
Posaconazole Impurity 18 |
213381-06-7 |
C37H42F2N8O4 |
 |
Secondary Prostaglandin Metabolite LC-MS Mixture |
|
|
 |
Indoline |
496-15-1 |
C8H9N |
 |
3-CYANOCOUMARIN |
15119-34-3 |
C10H5NO2 |
 |
N-(3-Fluoro-4-methyl-8-oxo-5,6,7,8-tetrahydro-1-naphthyl)acetamide |
143655-58-7 |
C13H14FNO2 |
 |
((1R,3R)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-5,6-dimethyl-6-(trimethylsilyloxy)hept-3-en-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)cyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane) |
2186604-89-5 |
C42H80O3Si3 |
 |
Anti-Cyclooxygenase 3/Cox3 |
|
|
 |
Ceftazidime and Avibactam Sodium for Injection |
|
|
 |
13,14-DIHYDRO-15-KETO PROSTAGLANDIN D2 |
59894-07-4 |
C20H32O5 |
 |
9-OXO-11ALPHA-15S-DIHYDROXY-PROSTA-5Z,13E-DIEN-1-OIC-3,3,4,4-D4 ACID |
34210-10-1 |
C20H28D4O5 |
 |
5-(4-Hydroxyphenyl)-2,4-imidazolidinedione |
2420-17-9 |
C9H8N2O3 |
 |
2-Azepan-1-yl-ethylamine |
51388-00-2 |
C8H18N2 |
 |
4,7-DIHYDROXYCOUMARIN |
1983-81-9 |
C9H6O4 |
 |
Fmoc-Gly-Gly-Phe-Gly-CH2-O-CH2-Cbz |
2264011-97-2 |
C40H41N5O9 |
 |
(9H-fluoren-9-yl)methyl (S)-(1-(methylamino)-1-oxo-5-ureidopentan-2-yl)carbamate |
|
|
 |
(9H-fluoren-9-yl)methyl (S)-(4-methyl-1-(methylamino)-1-oxopentan-2-yl)carbamate |
|
|
 |
(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline |
118864-75-8 |
C15H15N |
 |
(2S,3R)-2-amino-3-methylpent-4-enamide |
2209873-96-9 |
C6H12N2O |
![4alpha,5-epoxy-5alpha-androst-2-eno[2,3-d]isoxazol-17beta-ol](/CAS/20180808/GIF/20051-76-7.gif) |
4alpha,5-epoxy-5alpha-androst-2-eno[2,3-d]isoxazol-17beta-ol |
20051-76-7 |
C20H27NO3 |
 |
Carbamazepine intermediate |
|
|
 |
(6R,7S)-Ceftriaxone Epimer |
|
|